BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34761621)

  • 21. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.
    Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q
    Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
    J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.
    Cai B; Cai JP; Luo YL; Chen C; Zhang S
    Inflammation; 2015 Aug; 38(4):1599-608. PubMed ID: 25676437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reconstructing the JAK/STATs signal pathway restored the anti-proliferative response of MHCC97 on interferon alpha].
    Wu WZ; Sun HC; Gao YQ; Wang L; Tang ZY; Liu KD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):277-80. PubMed ID: 16635297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B; Xu L; Dai EN; Tian JX; Li JM
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice.
    Na YJ; Jin JK; Kim JI; Choi EK; Carp RI; Kim YS
    J Neurochem; 2007 Oct; 103(2):637-49. PubMed ID: 17897356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
    Wang L; Kurosaki T; Corey SJ
    Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An insight into JAK-STAT signalling in dermatology.
    Palanivel JA; Macbeth AE; Chetty NC; Levell NJ
    Clin Exp Dermatol; 2014 Jun; 39(4):513-8. PubMed ID: 24825142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
    Wu Z; Liu J; Hu S; Zhu Y; Li S
    Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK/STAT3 pathway by tubocapsenolide A.
    Zhu D; Chen C; Liu X; Wang S; Zhu J; Zhang H; Kong L; Luo J
    J Adv Res; 2021 Dec; 34():79-91. PubMed ID: 35024182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-146a down-regulation alleviates H
    Yang X; Mao X; Ding X; Guan F; Jia Y; Luo L; Li B; Tan H; Cao C
    Cell Biol Toxicol; 2018 Dec; 34(6):479-489. PubMed ID: 29484526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Downregulation of Herg1 suppresses osteosarcoma proliferation and invasion by targeting Hippo signaling pathway].
    Chen ZD; Ye WB; Zeng WR; Song C; Song W; Zhang YM; Wu J
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):338-345. PubMed ID: 31137166
    [No Abstract]   [Full Text] [Related]  

  • 39. [Impact and long-term effect of three prescriptions regulating and tonifying lung and kidney on JAK/STAT signaling in rats].
    Tian YG; Li Y; Li JS; Li SY; Jiang SL; Wang Y; Deng L; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):75-80. PubMed ID: 23596881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
    Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
    J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.